摘要
目的比较瑞替普酶(reteplase,r-PA)和尿激酶(Urokinase,UK)对急性心肌梗死(Acute Myocardial Infarction,AMI)溶栓的治疗效果。方法回顾性分析辽阳市中心医院312例接受溶栓治疗的AMI患者临床资料,分成r-PA组和UK组,统计两组的血管开通率、开通时间和出血发生率。结果 r-PA组血管总开通率为81.76%,UK组总开通率为52.82%,且r-PA发病时间<3 h溶栓后血管开通率高于发病时间>3 h组,r-PA组血管开通时间(1.1±0.47)h快于UK组(1.97±0.52)h。以上3组数据相比较差异均具有统计学意义(P<0.05)。r-PA组和UK组出血发生率比较差异无统计学意义(P>0.05)。结论 r-PA溶栓疗效优于UK。
Objective To compare the treatment effect between reteplase(r-PA) and urokinase(UK) in treating throm- bolysis after acute myocardial infraction (AMI). Methods The clinical data of 312 patients with AMI at our hospital undergoing thrombolytic therapy were retrospectively analyzed.All cases were divided into r-PA group and UK group. Reperfusion rate of blood vessel, reperfusion time of blood vessel and morbidity of hemorrhage were recorded.Results The total reperfusion rate of blood vessel in the r-PA group was 81.76% and 52.82% in the UK group respectively. The reperfusion rate of blood vessel within 3 hours after the onset of AMI was significantly higher than that over 3 hours after the onset of AMI in the r-PA group.The reperfusion time of blood vessel in the r-PA group was(1.1 + 0.47) hours, which was faster than(1.97 +_ 0.52) hours in the UK group.The differences of the three pairs of data had statistical sig- nificance(P〈0.05).The differences of hemorrhage morbidity between the r-PA group and the UK group were not of statistical significance(P〉 0.05).Conclusion r-PA is more effective than UK in treating thrombolysis after AMI.
出处
《中国疗养医学》
2016年第1期58-60,共3页
Chinese Journal of Convalescent Medicine
关键词
急性心肌梗死
瑞替普酶
尿激酶
溶栓疗法
Acute myocardial infarction
Reteptase
Urokinase
Thrombolytic therapy